Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Biologic psoriasis treatments are differentiated by efficacy, side effects, and other attributes. Objective: Determine attributes of biologic psoriasis treatments that drive patients’ treatment choices. Methods: Respondents (USA: n = 300; Germany: n = 300) with moderate-to-severe psoriasis completed a discrete-choice–experiment survey, choosing between hypothetical treatments characterized by attributes with varying levels: chance of clear skin after 1 year, number of first-year treatments, first-year risks of mild-to-moderate injection site reaction (ISR) and serious infection, and years of proven efficacy/safety. Results: U.S. respondents most valued clear skin (conditional relative importance, 1.88; p

Cite

CITATION STYLE

APA

Feldman, S. R., Poulos, C., Gilloteau, I., Mange, B., Boehm, K., Boeri, M., … Augustin, M. (2022). Exploring determinants of psoriasis patients’ treatment choices: a discrete-choice experiment study in the United States and Germany. Journal of Dermatological Treatment, 33(3), 1511–1520. https://doi.org/10.1080/09546634.2020.1839007

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free